SBI Capital Markets Ltd (\Manager to the Open Offer\) has submitted to BSE a copy of Detailed Public Statement in terms of Regulation 3(1) and Regulation 4 read with Regulation 13(4), Regulation 15(2) and other applicable Regulations of The Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended, to the Public Shareholders of Bliss GVS Pharma Ltd (\Target Company\).